Nintedanib benefits patients with autoimmune disease-related lung diseases
A new clinical published in Arthritis & Rheumatology reveals that nintedanib, a medication that helps prevent changes to lung tissue, may help patients with fibrosing autoimmune disease-related interstitial lung diseases ...